The protozoan parasite Leishmania is the causative agent of serious human infections worldwide. The parasites alternate between insect and vertebrate hosts, and cause disease by invading macrophages, where they replicate. Parasites lacking the ferrous iron transporter LIT1 cannot grow intracellularly, indicating that a plasma membrane-associated mechanism for iron uptake is essential for the establishment of infections. Here we identify and functionally characterize a second member of the Leishmania iron acquisition pathway, the ferric iron reductase LFR1. The LFR1 gene is up-regulated under iron deprivation, and accounts for all the detectable ferric reductase activity exposed on the surface of L. amazonensis. LFR1 null mutants grow normally as promastigote insect stages, but are defective in differentiation into the vertebrate infective forms, metacyclic promastigotes and amastigotes. LFR1 over-expression partially restores the abnormal morphology of infective stages but markedly reduces parasite viability, precluding its ability to rescue LFR1 null replication in macrophages. However, LFR1 over-expression is not toxic for amastigotes lacking the ferrous iron transporter LIT1, and rescues their growth defect. In addition, the intracellular growth of both LFR1 and LIT1 null parasites is rescued in macrophages loaded with exogenous iron. This indicates that the Fe 3+ reductase LFR1 functions upstream of LIT1, and suggests that LFR1 over-expression results in excessive Fe 2+ production, which impairs parasite viability after intracellular transport by LIT1.
The protozoan parasite Leishmania is the causative agent of serious human infections worldwide. The parasites alternate between insect and vertebrate hosts, and cause disease by invading macrophages, where they replicate. Parasites lacking the ferrous iron transporter LIT1 cannot grow intracellularly, indicating that a plasma membrane-associated mechanism for iron uptake is essential for the establishment of infections. Here we identify and functionally characterize a second member of the Leishmania iron acquisition pathway, the ferric iron reductase LFR1. The LFR1 gene is up-regulated under iron deprivation, and accounts for all the detectable ferric reductase activity exposed on the surface of L. amazonensis. LFR1 null mutants grow normally as promastigote insect stages, but are defective in differentiation into the vertebrate infective forms, metacyclic promastigotes and amastigotes. LFR1 over-expression partially restores the abnormal morphology of infective stages but markedly reduces parasite viability, precluding its ability to rescue LFR1 null replication in macrophages. However, LFR1 over-expression is not toxic for amastigotes lacking the ferrous iron transporter LIT1, and rescues their growth defect. In addition, the intracellular growth of both LFR1 and LIT1 null parasites is rescued in macrophages loaded with exogenous iron. This indicates that the Fe 3+ reductase LFR1 functions upstream of LIT1, and suggests that LFR1 over-expression results in excessive Fe 2+ production, which impairs parasite viability after intracellular transport by LIT1.
Human infections with the protozoan parasite Leishmania spp represent a serious public health problem. Depending on the parasite species, the clinical symptoms can range from self-healing cutaneous lesions to severe visceralizing disease, which is fatal if left untreated. Control of disease transmission is very challenging, since the parasite is transmitted by several sand fly species, which are present throughout the world in both rural and urban environments (1) . No vaccines are currently available, and there is a strong need for less toxic drugs for the treatment of human and animal infections. The identification of essential parasite nutrient uptake pathways is therefore of paramount importance for the development of novel therapeutic strategies. Iron is one of the four most abundant elements in the Earth's crust, but its uptake is a challenging problem for living cells (2) . Iron is an essential co-factor for many enzymatic activities, and therefore must be transported from the extracellular environment into the cytosol. However, the ferrous iron (Fe 2+ ) that is soluble at neutral pH cannot be allowed to accumulate, because it generates highly toxic radicals in the presence of oxygen (3) . For this reason, in aerobic environments iron is found mostly in the poorly soluble oxidized ferric form (Fe 3+ ), and stored as a complex with iron-binding proteins such as transferrin, lactoferrin, or ferritin. Prior to transport across membranes, Fe 3+ must be converted to Fe 2+ by a ferric iron reductase (4, 5) . Until recently, very little was known about the mechanism by which Leishmania deals with the problem of iron acquisition. An important advance was the identification and characterization of LIT1, a L. amazonensis plasma membrane Fe 2+ transporter. LIT1 is expressed by
Identification and cloning of LFR1 in L. amazonensis. Protein BLAST homology searches of the L. major database were used to identify LmjF30.1610, that shared 36% identity and 45% similarity to the Arabidopsis thaliana ferric reduction oxidase 1, FRO1. Primers AFPNA10 and AFPNA11 (Table S1) were designed based on the LmjF30.1610 DNA sequence to amplify the predicted open reading frame (ORF) of the putative ferric reductase gene from genomic DNA of L. amazonensis. Genomic DNA was isolated from 1x10 8 parasites in TELT buffer (50mM Tris-HCL, pH 8.0, 62.5 mM EDTA, 2.5 M LiCl, and 4% (v/v) Triton X-100) as previously described (12) . The resulting 3.5-kb product was cloned into the PCR4Blunt-TOPO vector (Invitrogen) to generate the plasmid pTOPO-LFR1 and the correct coding sequence was confirmed by sequencing. The resulting amino acid sequence was used to find the predicted FAD and NADH binding pockets by conserved domain analysis (NCBI, (13, 14) ). The topology of the protein was modeled with the SOSUI algorithm (15) and the resulted predicted transmembrane topology was used to locate the two transmembrane helices containing the four invariant histidines. The protein sequences for Leishmania major LFR1 (LmLFR1, accession no. XP_001684755), Arabidopsis thaliana FRO1 (AtFRO1, accession no. NP_171665), Arabidopsis thaliana FRO2 (AtFRO2, accession no. NP_171664), Pisum sativum FRO1 (PsFRO1, accession no. AAK95654), Homo. Sapiens GP91-PHOX (GP91-phox, accession no. P04839), and Saccharomyces cerevisiae FRE1 (ScFRE1, accession no. NP_013315) were downloaded from the National Center for Biotechnology Information server and aligned with CLUSTALW (16) . For LFR1 ectopic expression, the LFR1 ORF was cloned into the expression vector pXG-SAT (courtesy of S. Beverley, Washington University, St. Louis, MO) (17, 18) . The Leishmania pXG vectors, developed by the Beverley laboratory, utilize the dihydrofolate reductase-thymidylate synthase 5' and 3' UTR regions to control transcription, and reach ~10-20 copies per cell resulting in overexpression of cloned genes (18) . The LFR1 ORF was PCR amplified with the primer set AFPNA13/AFPNA20, digested with BamHI enzyme, and cloned into a BamHI linearized pXG-SAT plasmid to generate pLFR1-SAT. The gene  deletion  constructs  LaKOLFR1Hyg  and  LaKOLFR1Neo , required for sequential deletion of both alleles of the LFR1 gene, were based on the Leishmania expression vectors pXG-hyg and pXG-neo (courtesy of S. Beverly, (17)). A 1-kb flanking sequence upstream of the L. amazonensis LFR1 ORF was amplified using a nested PRC strategy utilizing the outer primer set (AFPNA25/AFPNA36) followed by the nested primer set (AFPNA35/AFPNA37). A 600-bp flanking sequence downstream of the L. amazonensis LFR1 ORF was amplified using a partial nested PCR strategy utilizing the outer primer set (AFPNA43/AFPNA38) followed by a second PCR using a primer set with one nested primer (AFPNA28/AFPNA43). The 5' and 3' flanking sequences were cloned into the pCR4-Blunt TOPO vector (Invitrogen) and sequenced to confirm identity of the fragments. The 5' and 3' flanking regions were amplified with the primer sets AFPNA45/AFPNA46, encoding NruI and EcoRV restriction sites, and AFPNA47/AFPNA48, encoding EcoRV and HindIII restriction sites, and subsequently cloned into pCR4-Blunt TOPO vector creating the plasmids p5'-topo and p3'-topo. The 5' flanking region was excised from the p5'-topo plasmid with SpeI and EcorV enzymes and cloned into the p3'-topo plasmid linearized with the same enzymes to create the p5'3'-topo plasmid. To generate the deletion constructs, the spanning regions containing the DHFR-Hyg (or Neo)-TS were PCR amplified from the pXG-based vectors with primers KO1 and KO2 and ligated into p5'3'-topo plasmid, linearized by EcorV digestion. Plasmid DNA from each gene-targeted construct was digested with NruI and HindIII to release the integrating fragments, and the linearized gene deletion constructs were gel purified.
Gene deletion constructs.
Transfection and generation of ∆lfr1 L. amazonensis. Transfections of L. amazonensis promastigotes were performed as outlined in Huynh et. al. (7) . For generation of the ∆ lfr1 knockout strain, the region containing the LFR1 gene was replaced sequentially on both alleles by the hygromycin B phosphotransferase (Hyg) and neomycin phosophotransferase (Neo) genes, to confer resistance to the antibiotics hygromycin B and G418, respectively. 100 µg/ml hygromycin B and/or 50 µg/ml G418 were added to the medium used to expand the isolated colonies after each round of homologous gene targeting. Southern blots were performed to determine integration of the selectable markers at the LFR1 locus. The digoxigenin (DIG) labeled probes for the Hyg, Neo, and LFR1 genes were generated by PCR amplification with primer sets AFPNA57/AFPNA58, AFPNA62/AFPNA63, and AFPNA14/AFPNA17, respectively, according to the manufacturer's protocol (Roche). Genomic DNA from candidate clones was isolated in TELT buffer as previously described (12) and digested with EcoRI /NotI (Hyg probed bots), EcoRI /MfeI (Neo probed blots) or MfeI/XhoI (LFR1 probed blots) enzymes overnight. The digests were ran on a 1% agarose gel and transferred to nylon membranes.
The blots were then blocked, hybridized and probed with DIG labeled PCR probes according to manufacturer's protocol (Roche).
The homozygous ∆lfr1 strain was cultured in promastigote media supplemented with 100 µg/ml hygromycin B and 50 µg/ml G418. Complementation of ∆lfr1 parasites with wild-type LFR1 was achieved by transfection of promastigotes with the episomal vector pLFR1-SAT. Agar-grown clones resistant to 50 µg/ml nourseothricin were selected for further characterization.
Quantification of LFR1 transcripts by qPCR. The effect of iron deprivation on the LFR1 transcript levels was ascertained by quantitative real time PCR analysis (qPCR). Log phase wildtype L. amazonensis promastigotes were washed twice in PBS, resuspended at 1x10 6 parasites per ml in promastigote medium lacking hemin, and incubated for 15 h at 26° C. A total of 1x 10 8 parasites were collected and total RNA was isolated from three independent samples using Qiagen RNeasy kit (Qiagen) according to the manufacturer's protocol. cDNA synthesis was carried out using 1 mg total RNA and qScript cDNA SuperMix (Quanta Biosciences). To quantify the levels of specific mRNA transcripts in individual samples, 1 ml of the cDNA was amplified with gene specific primers (LFR1 Fv/LFR1 Rv) and L. amazonensis ubiquitin hydrolase (UbuiqH FD/UbuiqH Rv) as a reference gene with PerfeCTa SYBR Green FastMix (Quanta Biosciences) following the manufacturer's protocol using a C1000 thermocycler with the CFX96 real-time system (BioRad). Three technical and three biological replicates of each reaction were performed, amplification efficiencies were validated and expression for LFR1 gene was normalized to the mRNAs encoding ubiquitin hydrolase which is known to be expressed constitutively in Leishmania (19, 20) .
Parasite growth assays. For procyclic promastigotes, a late-log phase culture of L. amazonensis was used to inoculate parasites at 1x10 5 parasites/ml in promastigote medium and incubated at 26°C. For axenic amastigotes, a log phase culture of L. amazonensis was used to inoculate parasites at 1x10 5 parasites/ml in amastigote medium and incubated at 32°C. A sample of the cultures were taken every 24 h and incubated with 5µM fluorescein diacetate (FDA) for 5 min. Fluorescent parasites were visualized with a Nikon Eclipse E200 microscope with a 40X NA 0.75 objective (Nikon) and counted on a brightline hemocytometer (Hausser Scientific). The data was analyzed for statistical significance using an unpaired Student's t test (P<0.05 was considered significant).
Iron reductase assays. The ability of parasites to reduce extracellular ferric iron to ferrous iron was measured with the cell impermeable compound potassium hexacyanoferrate [K 3 Fe(CN) 6 ] as previously described (9, 21) . Briefly, log phase promastigotes or axenic amastigotes were washed twice in PBS, resuspended at 1x10 6 parasites per ml in promastigote or amastigote media lacking or supplemented with hemin, and incubated for 15 h at 26°C for promastigotes and 32°C for amastigotes. The parasites were harvested by centrifugation, washed twice in PBS, and either 1x10 8 or 3x10 7 parasites were resuspended in 1 ml of HBSS containing 1 mM K 3 Fe(CN) 6 . The reduction of the ferric to ferrous form of K 3 Fe(CN) 6 was monitored by the change in absorbance at 420 nm. Samples (50 µl) were taken every hour, centrifuged at 10,000 g for 5 min, and read on a SpectraMax 5e plate reader (Molecular Devices). A standard curve of K 3 Fe(CN) 6 was used to convert OD 420 readings into millimolar K 3 Fe(CN) 6 . Data was plotted with Microsoft Excel (Microsoft) and line-fitted to determine rates of Fe 3+ reduction. Field Emission Scanning Electron Microscopy. Log phase promastigotes, seven-day stationary phase metacyclic, or axenic amastigotes were attached to poly-L-lysine coated glass coverslips and fixed for 2 h in 2% glutaraldehyde, 2% paraformaldehyde, 0.1 M HEPES pH 7.0 at room temperature.
Samples were then postfixed in 1% OsO4 in 0.1 M HEPES pH 7.4 for 1 h and then exposed to 1 % tannic acid (in water) for 1 h before dehydration in an ethanol series, critical point dried from CO 2 and gold-sputtered (22). Images were acquired on a Hitachi S-4800 field emission scanning electron microscope operated at 5 kV. All reagents were obtained from Electron Microscopy Sciences.
Live microscopy. To determine the percentage of live and dead parasites, samples were taken 48 h after transfer to amastigote media at 32°C and incubated with 5 µM fluorescein diacetate (FDA), to detect living parasites (green fluorescence), and 150 µM propidium iodide (PI), to detect dead parasites (red fluorescence), for 5 min at room temperature.
Parasites were transferred to a brightline hemocytometer and counted on a Nikon Eclipse E200 microscope with a 40X NA 0.75 objective (Nikon). To determine the percentage of motile versus non-motile parasites, samples of axenic amastigotes were taken at 48 h post induction and observed via phase contrast microscopy on a Nikon Eclipse E200 microscope with a 40X NA 0.75 objective. Parasites were scored as motile if movement of the parasite or flagellar beating was observed. Parasites failing to meet the former criteria were scored as non-motile. To determine parasite length, 48 h post induction axenic amastigotes or seven-day stationary phase metacyclic promastigotes were imaged by differential interference contrast microscopy (DIC) on a Nikon Eclipse Ti inverted microscope with a 100x NA 1.4 objective (Nikon) equipped with a Hamamatsu C9100-50 camera. Acquired images were analyzed with the Volocity Software Suite (PerkinElmer).
Immunofluorescence microscopy. 48 h post-induction axenic amastigotes or mid-log phase promastigotes were harvested, washed three times in PBS, and fixed with 4% PFA. The fixed parasites were permeabilized with 0.05% Triton X-100, washed in PBS, and adhered to Poly-Llysine coated coverslips.
The samples were blocked with 5% horse serum in PBS for 1 h, and incubated with mouse monoclonal antibodies against the P4 antigen (23) (courtesy of D. McMahon-Pratt, Yale University, New Haven, CT) for 1 h at room temperature. After incubation, the coverslips were washed three times with PBS and incubated with Texas Red conjugated goat anti-mouse antibodies (Invitrogen) for 1 h at room temperature. The coverslips were then washed three times with PBS, incubated with 36 µM DAPI, washed with PBS, and mounted in ProLong mounting media (Invitrogen) prior to imaging on a Leica TCS SP5 X Supercontinuum Confocal using a 63X NA 1.2 objective. Image acquisition was performed with the Leica application suite software package. Image analysis was performed with the Volocity Software Suite.
Infection of primary bone marrow macrophages. Bone marrow-derived macrophages from BALB/c mice (NCIS) were prepared as described previously (24), seeded onto 24-well plates containing coverslips at a density of 7 x 10 4 cells per well and incubated overnight in BMM media (RPMI 1640 supplemented with 10% FBS and 5% L cell supernatant (as a source of M-CSF)) at 37°C and 5% CO 2 . Adherent macrophages were washed with fresh RPMI 1640 and infected with axenic amastigotes in 0.5 ml RPMI 1640 supplemented with 5% FBS (multiplicity of infection = 1.0 or 1.5 ). After 1 h at 34°C and 5% CO 2 , free parasites were removed by three washes with PBS, and further incubated for various amounts of time in RPMI 1640 supplemented with 10% FBS and 5% L cell supernatant at 34ºC and 5% CO 2 .
For rescue experiments with cationic ferritin, macrophages were isolated and plated as outlined above. One hour before infection, BMM media was replaced with fresh BMM media supplemented with 10 µg/ml cationized ferritin from horse spleen (Sigma). Adherent macrophages were washed with fresh RPMI 1640 and infected with axenic amastigotes in 0.5 ml RPMI 1640 supplemented with 5% FBS (multiplicity of infection = 1.0). After 1 h at 34°C and 5% CO 2 , cultures were washed with PBS to remove extracellular parasites, and further incubated for various amounts of time in BMM media supplemented with 10 µg/mL cationized ferritin.
Coverslips were fixed after 1 h (0 h time point), 24 h, 48 h, and 72 h of incubation with 2% PFA, permeabilized with 0.02% Triton X-100, and stained with 35 µM DAPI. The number of intracellular parasites (identified through the characteristic kinetoplast DNA staining pattern with DAPI and localization within parasitophorous vacuoles by phase contrast) was quantified on a Nikon Eclipse E200 microscope with a 100X NA 1.4 objective (Nikon) in a minimum of 400 macrophages per coverslip, in triplicate. The data were expressed as the total number of intracellular parasites per 100 macrophages. The data were analyzed for statistical significance using an unpaired Student's t test (P < 0.01 was considered significant). Images of the infected macrophages were taken with a Nikon DS-Fi1 camera and processed with the Volocity Software Suite.
In vivo virulence and persistence assays. Female BALB/c mice were injected in the right hind footpad with 1.0 x 10 6 mAb 3A.1-purified metacyclic promastigotes of L. amazonensis (10,11) and lesion progression was followed by blinded weekly measurements with a caliper. The parasite tissue load of wild type and ∆lfr1 L. amazonensis was determined after nine or eleven weeks, respectively, using a limiting dilution assay (7, 25) .
Promastigotes derived from parasites isolated from footpad lesions were transferred to amastigote axenic media and subsequently used for infections in BMM. Statistical significance between means of the two groups was determined using a two-tailed Student's t test for independent samples.
Results
The Leishmania LFR1 gene encodes a membrane protein with ferric reductase activity that is induced by iron deficiency. Homology searches of the L. major database identified LmjF30.1610, a gene on chromosome 30 (Genebank accession number XP_001684755) with 36% identity and 45% similarity to FRO1, the ferric reduction oxidase gene from Arabidopsis thaliana. PCR amplification and cloning of the corresponding 3.5 kb LFR1 from genomic DNA of L. amazonensis (the species responsible for cutaneous leishmaniasis in the New World) revealed extensive identity with the L. major sequence ( Figure S1 ). LFR1 contains the PFAM ferric reductase-like transmembrane component (Ferric_reduct (PF01794)) found in other NADPH-dependent oxidoreductases (A. thaliana FRO1 and FRO2; S. cerevisiae FRE1 and FRE2; S. pombe FRP1; H. sapiens GP91-phox), along with the ferric reductase NAD binding domain (NAD_binding_6 (PF08030)) and the FADbinding domain (FAD_binding_8 (PF08022)), which together promote transmembrane electron transfer (26) . Specifically, LFR1 contains the highly conserved residues HPFT in the FADbinding motif, the residues GPyG in the NADbinding motif, and the four invariant transmembrane histidines that are found in A. thaliana FRO1 and FRO2, P. sativum FRO1, and S. cerevisiae FRE1 (27-29)( Figure S2 ).
The LFR1 gene encodes a 1084 amino acid protein with a calculated molecular mass of 119 kDa. Hydropathy analysis predicts 11 transmembrane domains, including an apparent Nterminus signal peptide. The C-terminal region containing the FAD-and NADPH-binding sites is predicted to be in contact with the cytosol. Four conserved histidines likely to mediate heme binding (29, 30) are present in transmembrane domains 9 (residues H458 and H472) and 11 (residues H542 and H556) ( Figures 1A, S1 ).
The sequence similarity with Arabidopsis FRO1 and the presence of functionally conserved motifs suggested that LFR1 encodes a plasma membrane ferric reductase. To directly test this hypothesis, we performed ferric reductase activity assays utilizing the membrane impermeable compound, hexacyanoferrate, as a means to monitor the ferric reductase active present on the surface of live promastigote forms of the parasites. Consistent with the high levels of sequence identity between LFR1 from L. amazonensis and the corresponding genes in L. major (causative agent of cutaneous leishmaniasis in the Old World) (Figure S1 ), live promastigotes from five distinct Leishmania isolates were able to reduce extracellular ferric iron. Higher levels of reductase activity were observed associated with species that cause cutaneous lesions (L. major, 1.40 ± 0.29 fmol hexacyanoferrate/h/cell; L. amazonensis, 1.27 ± 0.18 fmol hexacyanoferrate /h/cell), when compared to species that cause visceral disease (L. donovani, 0.55 ± 0.16 fmol hexacyanoferrate /h/cell; L. chagasi, 0.47 ± 0.09 fmol hexacyanoferrate /h/cell; L. infantum, 0.49 ± 0.03 fmol hexacyanoferrate /h/cell) ( Figure 1B) .
In order to demonstrate that LFR1 directly confers ferric reductase activity to Leishmania, L. amazonensis promastigotes were transfected the LFR1 over-expressing vector, pLFR1-SAT or vector alone. Parasites transfected with pLFR1-SAT showed a 3 fold increase in ferric reductase activity levels (from 1.37 ± 0.09 fmol hexacyanoferrate /h/cell to 4.39 ± 0.44 nm fmol hexacyanoferrate /h/cell) ( Figure 1C ). These assays were performed with promastigotes incubated for 15 h in media lacking the major source of iron, hemin, because several previously described reductases are induced by iron deficiency (4, 5) . As predicted, LFR1 transcript levels were >3 fold higher in L. amazonensis promastigotes incubated in iron-deficient media, when compared to parasites kept in the presence of hemin (Figure 2A ). In addition, the reductase activity of the parasites grown in iron-deficient media was increased by 27 % (from 0.87 ± 0.10 fmol to 1.19 ± 0.16 fmol hexacyanoferrate/h/cell) when compared to parasites grown in the presence of hemin ( Figure 2B) .
LFR1 is the major surface ferric reductase of L. amazonensis promastigotes. Two sequential rounds of transfection of L. amazonensis promastigotes with LFR1 gene deletion constructs followed by drug selection were used to generate heterozygote (LFR1/∆lfr1) and homozygote null (∆lfr1/∆lfr1) clones ( Figure 3A) . No growth defects in complete promastigote culture media was observed between wild type (LFR1/LFR1) and LFR1 null (∆lfr1/∆lfr1) promastigotes ( Figure 3C ), allowing expansion of the null strain. Ferric reductase activity was reduced in LFR1/∆lfr1 consistent with a single copy gene deletion, and undetectable in null ∆lfr1/∆lfr1 parasites. The ferric reductase activity, calculated from the linear slope fitted to the data, was the following: LFR1/LFR1:
1.68 ± 0.17 fmol hexacyanoferrate/h/cell; LFR1/∆lfr1: 0.49 ± 0.13 mM fmol hexacyanoferrate /h/cell; ∆lfr1/∆lfr1: not detectable ( Figure 3B ). This result demonstrates that LFR1 encodes the major ferric reductase protein exposed on the surface of Leishmania promastigotes. LFR1 is thus likely to be the major enzyme responsible for the conversion of Fe 3+ into Fe 2+ for intracellular transport by the Leishmania membrane transporter LIT1 (6,7).
LFR1-deficient L. amazonensis promastigotes are defective in differentiation into infective metacyclic and amastigote forms. Wild type and LFR1 null (∆lfr1) L. amazonensis promastigotes were grown to stationary phase, a condition that induces differentiation to metacyclic promastigote forms capable of initiating infections in mammalian hosts (31) . The expected number of metacyclic promastigotes was isolated from cultures of wild type L. amazonensis. In contrast, there was a five-fold reduction in the number of metacyclic promastigotes (defined as not being agglutinated by the 3A.1 mAb) isolated from ∆lfr1 L. amazonensis cultures ( Figure 4A ).
Scanning electron microscopy (SEM) examination showed that wild type and ∆lfr1 parasites present in mid-log phase had a normal morphology, typical of replicating promastigote forms. However, examination of stationary phase cultures revealed striking morphological alterations in the ∆lfr1 strain. While most wild type parasites from the stationary phase cultures had the elongated cylindrical morphology typical of this life cycle stage, ∆lfr1 parasites showed a very heterogeneous morphology, ranging from long cylindrical forms resembling normal metacyclic forms to bulbous forms displaying long flagella ( Figure 4B ). In order to quantify this phenotype, wild type parasites transfected with vector alone and ∆lfr1 parasites transfected with pLFR1-SAT or vector alone were grown to stationary phase and subjected to microscopic imaging and long-axis cell body measurements. Wild type parasites transfected with vector alone displayed elongated forms with the majority of the cell bodies ranging from 7 to 12 µ m in length, whereas ∆lfr1 parasites transfected with vector alone had a heterogeneous distribution of cell body length, ranging from 4 to 14 µm. The ∆lfr1 promastigotes transfected with pLFR1-SAT displayed a partially restored morphology, as determined by long-axis cell body measurements. However, although the number of elongated cylindrical forms typical of metacyclic promastigotes was increased, numerous shorter and bulbous forms were still present ( Figure 4C ). Transfection of wild type and ∆lfr1 promastigotes with the empty pXG-SAT vector did not alter the metacyclic form morphology observed in the absence of transfection (data not shown).
Next, we investigated whether LFR1 was required for the generation of amastigotes, the rounded, non-motile Leishmania life cycle stages that replicate within host macrophages. In L. amazonensis, promastigotes can be induced to differentiate into axenic amastigotes, by shifting the parasites to culture medium that resembles the intracellular conditions of low pH (pH 4.5) and elevated temperature (32°C) (32) . When this procedure was performed in parallel with wild type and ∆lfr1 promastigotes, wild type parasites differentiated normally and replicated as axenic amastigotes. In contrast, no detectable growth as amastigotes was observed with ∆lfr1 parasites ( Figure 5A ). After 48 h of incubation in amastigote medium, 95% of wild-type parasites had assumed the rounded amastigote morphology and were no longer motile, while only 60% of ∆lfr1 parasites were non-motile ( Figure 5B ). The viability of ∆lfr1 parasites was also reduced under these conditions, as determined with a fluorescent live/dead assay ( Figure 5C ). SEM analysis of the morphology of parasites after 48 h in amastigote culture conditions showed that recently differentiated wild type amastigotes had the expected rounded and compact cell shape, while ∆lfr1 parasites showed a more heterogeneous morphology, with different degrees of incomplete shortening of the cell body and flagella ( Figure  5D ). Despite the observed differences in morphological differentiation, both wild type and ∆lfr1 L. amazonensis expressed the amastigote marker P4 (23) when promastigote cultures were shifted to amastigote growth medium ( Figure 5E ). These findings suggest that in the absence of LFR1 the differentiation process into amastigotes is initiated, but is not completed.
Transfection with pLFR1-SAT, followed by a shift to amastigote medium at 32°C and pH 4.5, resulted in increased ferric reductase activity, from 0.71 ± 0.10 to 4.32 ± 0.60 fmol hexacyanoferrate /h/cell in wild type, and from undetectable levels to 1.98 ± 0.08 fmol hexacyanoferrate /h/cell in ∆lfr1 promastigotes ( Figure 6A ). The increase in LFR1 expression did not rescue the inability of ∆lfr1 to grow as axenic amastigotes ( Figure 6B ). Notably, LFR1 overexpression markedly inhibited the growth of wild type axenic amastigotes, suggesting a toxic effect ( Figure 6B ). Viability assays confirmed an increase in the number of dead parasites after LFR1 over-expression, in both wild type and ∆lfr1 parasites ( Figure 6C) . Imaging followed by cell body length measurements revealed that LFR1 expression in ∆lfr1 parasites only partially restored the morphological shift from the elongated promastigote shape to the shortened, round amastigotes ( Figure 6D) .
To determine the infectivity of these forms, parasites transfected with pXG-SAT alone or pLFR1-SAT were incubated for 48 h in amastigote medium and infection of bone marrow-derived mouse macrophages (BMM) was performed. In agreement with their inability to replicate as axenic amastigotes, ∆lfr1 parasites did not replicate within macrophage phagolysosomes. In contrast, wild type parasites expressing the empty vector showed vigorous intracellular replication, confirming that transfection alone did not reduce parasite viability. The inhibition in intracellular growth was also not due to an attenuation caused by extended culturing, as ∆lfr1 parasites freshly isolated from mice displayed the same phenotype (Supplemental Figure S3) . A strong inhibition in the intracellular replication of both wild type and ∆lfr1 parasites was observed when LFR1 was over-expressed, consistent with the toxic effect of high levels of LFR1 ( Figure 6E ).
In order to determine if the inability ∆lfr1 amastigotes to replicate within cultured BMM also occurred in vivo, wild type and ∆lfr1 metacyclic promastigotes were inoculated into the footpads of Balb/c mice. As shown in Figure 4A , despite the reduction in number, metacyclic parasites could be purified from the mixed morphology 7 day stationary phase cultures of ∆lfr1. As expected, a progressive growth in the size of cutaneous lesions was observed in mice injected with wild type L. amazonensis metacyclic promastigotes. In contrast, lesion development was significantly delayed in mice inoculated with ∆lfr1 metacyclic promastigotes ( Figure 6F ).
Because lesion development measurements based on footpad swelling reflect inflammation and not the absolute number of parasites in the tissue, quantification of parasite load in the mouse footpads was also performed using a limiting dilution assay (33) . The average number of ∆lfr1 parasites per footpad was reduced by a factor of 10 6 when compared to wild type parasites ( Figure 6G ), demonstrating their impaired virulence.
LFR1 over-expression inhibits growth of wild type L. amazonensis amastigotes, but rescues replication of amastigotes lacking the Fe
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transporter LIT1. The results discussed above indicate that LFR1 is required for the transformation of L. amazonensis promastigotes into amastigotes, and for their sustained axenic growth. Over-expression of LFR1 was found to have toxic effects on the parasites, precluding a rescue of the metacyclic and amastigote differentiation defects. This finding was not totally unexpected, since it is known that cells have to exert tight control over the levels of cellular Fe 2+ , to avoid the generation of toxic radicals in aerobic environments (3) . To test the hypothesis that the toxicity caused by overexpression of LFR1 is a result of excessive production and uptake of Fe 2+ , we over-expressed LFR1 in ∆lit1, a L. amazonensis null mutant lacking the Fe 2+ iron transporter, LIT1 (7). Reflecting the endogenous levels of LFR1, wild type and ∆lit1 promastigotes transfected with pXG-SAT alone had similar levels of ferric reductase activity (wild type (Vector)=1.01 ± 0.09 fmol hexacyanoferrate/h/cell; ∆lit1 (Vector)=1.03 ± 0.09 fmol hexacyanoferrate/h/cell), while ∆lit1 promastigotes transfected with pLFR1-SAT showed the expected activity increase (∆lit1 (LFR1)=4.66 ± 0.90 fmol hexacyanoferrate/h/cell) ( Figure 7A ). This pattern of expression was maintained when the transfected promastigotes were induced to differentiate into axenic amastigotes at pH 4.5 at 32°C (wild type (Vector)=0.63 ± 0.15 f mol hexacyanoferrate/h/cell; ∆lit1 (Vector)=0.90 ± 0.14 fmol hexacyanoferrate/h/cell; ∆lit1 (LFR1)=3.38 ± 0.05 fmol hexacyanoferrate /h/cell) ( Figure 7B ). When the rate of growth of these transfected parasites as axenic amastigotes was determined, we observed a reduction in ∆lit1 replication when compared to wild type parasites, which is consistent the data presented above and with the results of previous studies (7) . Remarkably, over-expression of LFR1 in ∆lit1 did not result in the toxic effects observed in wild type L. amazonensis ( Figure 6B ), allowing vigorous amastigote replication and a full rescue of the ∆lit1 growth defect ( Figure 7C ).
Previous studies revealed that ∆lit1 amastigotes were unable to replicate in BMM (7). To test if over-expression of LFR1 rescued the growth of intracellular amastigotes, wild type and ∆lit1 parasites transfected with pXG-SAT alone or pLFR1-SAT were used to infect BMM. As previously reported, the number of intracellular ∆lit1 amastigotes decreased over time (7) . In contrast, over-expression of LFR1 led to a significant increase in the numbers of intracellular amastigotes,when compared to ∆lit1 parasites transfected with vector alone ( Figure 7D) . Thus, the toxic effects of LFR1 over-expression on axenic or intracellular amastigotes require expression of the Fe 2+ iron transporter LIT1. LFR1 deficient parasites are able to replicate within macrophages loaded with an exogenous source of iron. Cationic ferritin binds to negative charges on the plasma membrane, is endocytosed, concentrated in lysosomes, and degraded releasing Fe 3+ for transport to the cytoplasm (34, 35) . Since ∆lfr1 parasites retain a functional LIT1 transporter that promotes ferrous iron acquisition by amastigotes within phagolysosomes (7), we hypothesized that loading the lysosomal compartment of macrophages with excess exogenous iron should be able to promote the replication ∆lfr1 amastigotes. To test this hypothesis, BMM were incubated in BMM medium alone or BMM medium supplemented with 10 µg/ml of cationic ferritin for 1 h, followed by infection with wild type, ∆lfr1, and ∆lit1 parasites. As expected, ∆lfr1 and ∆lit1 parasites failed to replicate in BMM grown in regular BMM medium, while the number of wild type parasites increased progressively between 24 and 72 h after infection ( Figure 8A,B) . However, in BMM pre-incubated with cationic ferritin, wild type, ∆lfr1 and ∆lit1 parasites all displayed progressive intracellular growth, and formed the typically enlarged parasitophorous vacuoles containing multiple amastigotes ( Figure  8A ,B).
Discussion
Evidence has been accumulating in support of the notion that Leishmania spp. can obtain iron from a variety of sources, including heme, hemoglobin, transferrin, lactoferrin, or ferric nitrilotriacetate (36) (37) (38) (39) (40) . However, unlike mammalian cells, these protozoan parasites do not appear to utilize a receptor-mediated mechanism for the uptake of Fe 3+ chelated to carrier proteins such as transferrin (6, 9, 40) . Rather, Leishmania directly translocates iron across their plasma membrane through LIT1, a ZIP family Fe 2+ membrane transporter that is expressed on the plasma membrane of L. amazonensis under conditions of iron deprivation (7). LIT1-deficient parasites are unable to replicate within host macrophages and do not cause skin lesions in mice, indicating that this pathway of iron acquisition is essential for the ability of Leishmania to cause disease (7) .
Ferrous iron transporters are expected to work in concert with ferric reductases, which are essential for the generation of the soluble Fe 2+ substrate for membrane translocation (4). Indeed, earlier studies using membrane impermeable substrates detected a NADPH-dependent ferric reductase activity associated with intact promastigote stages of L. chagasi, suggesting a plasma membrane association for this enzyme (9) . In this work we have identified LFR1, a gene induced under low iron availability that accounts for all the detectable ferric iron reductase activity associated with the surface of L. amazonensis promastigotes. The LFR1 gene and the surfaceassociated ferric reductase activity are present in several Leishmania species, including L. infantum, L. chagasi and L. donovani, species that cause visceralizing disease ( Figure 1B) . Interestingly, under the culture conditions utilized the species causing visceralizing infections expressed lower levels of LFR1 activity that the species that induce cutaneous lesions. This observation suggests the existence of differences in iron acquisition and homeostasis pathways that might be associated with the different environments encountered by the parasites in vivo. The characterization of LFR1 null mutants performed in this study indicate that the ferric reductase LFR1 is essential for the ability of Leishmania to differentiate into infective forms, and to establish infections.
LFR1 is predicted to have multiple transmembrane domains, a bis-heme binding motif, and a cytoplasmic loop that includes FAD and NADH binding sites ( Figure 1A, Figure S2 ). These three motifs are a hallmark of the large family of NADPH oxidases (NOX), of which one of the best characterized members is GP91-phox, a protein essential for superoxide production by phagocytes (41) (Figure S2 ). NOX proteins transfer electrons from NADPH in the cytosol, across the lipid bilayer via the non-covalently bound FAD and histidine-coordinated heme, to an acceptor molecule on the outer face of the membrane (42) . In the case of the GP91-phox the acceptor molecule is molecular oxygen, whereas for ferric reductases the electron acceptor is Fe 3+ , which is converted to Fe 2+ (28, (43) (44) (45) .
The Leishmania LFR1 protein shows close similarity to the ferric reductases of A. thaliana (FRO1 and FRO2) and P. sativum (FRO1) that are involved in root iron acquisition (28, 29, 45) . LIT1, the only additional Leishmania gene identified to date with a role in iron acquisition, was also identified based on its close similarity to an Arabidopsis gene, the ZIP family ferrous iron transporter IRT1. Interesting questions regarding the phylogenetic origin of genes involved in iron acquisition and homeostasis in these ancient trypanosomatid protozoa are likely to emerge, as soon as additional genes involved in these pathways are identified.
Despite its severe defect in differentiation into infective life cycle stages, LFR1 null mutants grow normally as promastigotes, the insect forms that can be axenically cultivated in the presence of abundant sources of iron. Since LFR1 expression is up-regulated upon iron deprivation, it is conceivable that in iron-abundant environments Leishmania sp. utilizes low affinity iron transport systems, as described for Saccharomyces cerevisiae (4) . Alternatively, cultured promastigotes may be able to internalize iron in a form that is independent of Fe 3+ to Fe 2+ conversion by a plasma membrane ferric reductase. Leishmania parasites are heme auxotrophs, and promastigotes have been proposed to have plasma membrane receptors and/or transporters that mediate heme uptake (36, 38) , raising the possibility that heme can serve as a source of iron for these parasites.
Under conditions that promote differentiation into metacyclic promastigotes or axenic amastigotes, the essential role of LFR1 in L. amazonensis becomes evident. Without the LFR1 reductase, even in the presence of abundant sources of iron, differentiation into infective stages is incomplete and viability is reduced. Because over-expression of LFR1 inhibits parasite growth and reduces viability, we could not directly demonstrate with complementation assays that the differentiation defects of the null mutant are directly attributable to the absence of LFR1. However, taking advantage of the ability to load macrophage endosomal compartments with exogenous iron, we were able to rescue the intracellular growth of LFR1 null parasites. This result indicates that under excess iron availability, the need for reduction of Fe 3+ to Fe 2+ by LFR1 can be bypassed, possibly through the generation of Fe 2+ by the lysosomal reductase LCytb (46) . In addition, utilizing a null mutant lacking the LIT1 Fe 2+ transporter (7), we showed that LFR1 overexpression rescues the growth defect of LIT1 null amastigotes, perhaps by providing additional substrate for alternative, lower affinity Fe 2+ transporters. This result provides strong evidence in support of the hypothesis that LFR1 functions upstream of LIT1, by generating the ferrous form of iron that can be transported across the parasite's membrane. Furthermore, our results strongly suggest that the toxicity of LFR1 over-expression is a direct consequence of increased Fe 2+ production. Without LIT1 to transport Fe 2+ intracellularly, LFR1 over-expression is no longer toxic, which allowed us to demonstrate that LFR1 can compensate for the growth defect of LIT1 null mutant amastigotes. Taken together, our results show that the Leishmania transmembrane protein LFR1 functions as a ferric iron reductase, converting extracellular chelated Fe 3+ into the soluble Fe 2+ form, which is then transported into the parasites by the ZIP family transporter LIT1. medium containing hemin (white columns) or medium lacking hemin (black columns) for 15 h at 26°C. (A) A total of 1x10 8 parasites were collected, total RNA was isolated, and transcript levels were quantified by qPCR. The data represent the mean ± SD of triplicate determinations and are representative of three independent experiments. LRF1 transcript levels from parasites grown in media lacking hemin were increased 2.5 fold when compared to parasites grown in complete media. (B) After 15 h incubation in the presence or absence of hemin, the parasites were resuspended in assay buffer at 1x10 8 parasites/ml, and ferric reductase activity was monitored spectrophotometrically. Parasites grown without hemin had a significant increase in reductase activity, when compared to parasites grown in complete hemincontanining media (Student's t test, p < 0.01). The data represent the mean ± SD of triplicate determinations and are representative of three independent experiments. 8 parasites were used to isolate metacyclic forms from seven-day stationary phase promastigote cultures by preferential agglutination of promastigotes with the 3A.1 mAb. The data represent the mean number of metacyclic forms recovered ± SD of triplicate determinations, and is representative of at three independent experiments. (B) Parasites from mid-log or stationary phase cultures were adhered to poly-lysine coated coverslips and processed for scanning electron microscopy. Images show representative morphological forms for each condition. Quantification of a total of 140 ∆lfr1 parasites revealed three main morphological forms: long cylindrical (35%), long bulbous (31%), or short bulbous (34%). Scale bars = 5 µm. (C) Wild type and ∆lfr1 parasites were transfected with empty pXG-SAT vector (wild type (Vector); ∆lfr1 (Vector)) or pLFR1-SAT (∆lfr1 (LFR1)), and grown to stationary phase. Parasites from each strain were imaged by DIC and the longest cell body axis measured as indicated with the white lines in the insets. Wild type length = 12.0 µm, ∆lfr1 (Vector) = 5.0 and 8.5 µm, ∆lfr1 (LFR1) = 13.5 µm. A total of 300 parasites were measured for each strain. The data represent the mean ± SD of quadruplicate determinations. (D) Samples of wild type and ∆lfr1 amastigote cultures were adhered to poly-lysine coated coverslips and processed for scanning electron microscopy. Scale bars = 5 µm. (E) Samples were taken from wild-type and ∆lfr1 mid-log cultures, or 48 h axenic amastigote cultures, fixed, permeabilized, and stained by immunofluorescence with antibodies against the amastigote-specific antigen P4 (red) and the nuclear stain DAPI (grey). The white arrows indicate an incompletely differentiated ∆lfr1 parasite displaying P4 staining. Scale bars = 5 µm. Figure 6 . LFR1 null L. amazonensis have a strong growth defect as axenic amastigotes and have reduced virulence. LFR1 over-expression partially rescues the defective differentiation defect of LFR1 null L. amazonensis, but impairs viability and replication of wild type and LFR1 null parasites. Wild type and ∆lfr1 promastigotes were transfected with the pXG-SAT vector alone (Vector) or pLFR1-SAT (LFR1). Mid-log phase promastigotes were resuspended in amastigote growth media at 1x10 5 parasites/ml and cultured at 32°C. (A) Ferric reductase activity of axenic amastigotes after 48 h in amastigote media. Wild type ( ) and ∆lfr1 ( ) parasites transfected with pLFR-SAT1 have higher ferric reductase activity than wild type ( ) or ∆lfr1 ( ) transfected with vector alone. The data represent the mean ± SD of triplicate determinations. (B) Growth curves of wild type and ∆lfr1 parasites transfected with vector alone (Vector) or pLFR1-SAT (LFR1). The data represent the mean ± SD of quadruplicate determinations. The asterisk indicates significant differences between wild type (Vector) and wild type (LFR1) (Student's t test, p < 0.02). (C) Parasite viability was determined 48 h after switching to amastigote media by incubation with 5 µM fluorescein diacetate (green) and 150 µM propidium iodide (red). Green fluorescent parasites were scored as "live" while red fluorescent parasites were scored as "dead". The data represent the mean ± SD of quadruplicate determinations. The asterisk indicates significant differences between wild type (Vector) and wild type (LFR1), or between ∆lfr1 (Vector) and ∆lfr1 (LFR1) (Student's t test, p < 0.02). (D) Wild type and ∆lfr1 parasites were imaged by DIC and the cell body axis measured as indicated in the insets (n=300). (E) BMM were infected for 1 h with parasites cultured for 48 h in amastigote growth media (MOI = 1.5) and fixed after the indicated periods for determining the number of intracellular parasites. The data represent the mean ± SD of the results of three independent experiments. The asterisk indicates significant differences when wild type (Vector) was compared to ∆lfr1 (Vector), wild type (LFR1) or ∆lfr1 (LFR1) (Student's t test, p < 0.01). (F,G) BALB/c mice were inoculated in the left hind footpad with 1x10 6 wild type or ∆lfr1 purified metacyclic forms. (F) Lesion development was measured by weekly caliper measurements. The data correspond to the mean ± SD of values from five mice. The asterisks indicate significant differences between wild type (Vector) and ∆lfr1 (Vector) (Student's t test, p < 0.0002). (G) Parasite loads were determined by limiting dilution in footpads of mice inoculated with wild type or ∆lfr1. The asterisks indicate significant differences between wild type (Vector) and ∆lfr1 (Vector) (Student's t test, p < 0.003). Figure 7 . Over-expression of LFR1 in LIT1 null L. amazonensis is not toxic, and rescues axenic and intracellular replication of amastigotes. Wild type and ∆lit1 L. amazonensis promastigotes were transfected with vector alone or pLFR1-SAT. Mid-Log phase promastigotes and axenically grown amastigotes were washed and transferred to promastigote or amastigote media lacking hemin, respectively. After 15 h at 26° C (A -promastigotes) or 32°C (B -amastigotes), parasites were washed and assayed for ferric reductase activity at 1x10 8 parasites/ml. The data represent the mean ± SD of triplicate determinations and are representative of at least four independent experiments. (B) Axenic amastigotes from wild type ( ) and ∆lit1 ( ) promastigotes transfected with vector alone had similar ferric reductase activity, while ∆lit1 amastigotes transfected with pLFR1-SAT ( ) had increased ferric reductase activity. (C) Growth rates of wild type ( ) and ∆lit1 ( ) L. amazonensis axenic amastigotes transfected with pXG-SAT vector alone, and ∆lit1 transfected with pLFR1-SAT ( ). Over-expression of LFR1 gene is not deleterious to growth of ∆lit1 parasites, and complements the growth defect seen in ∆lit1 transfected with vector alone. The data represents the mean ± SD of triplicate determinations. The asterisk indicates a significant difference between wild type (Vector) and ∆lit1 (Vector) (Student's t test, p < 0.01). (D) BMM were infected (MOI = 1.0) for 1 h with axenic amastigotes (wild type and ∆lit1 parasites transfected with vector alone or ∆lit1 parasites transfected with pLFR1-SAT) and fixed after the indicated incubation periods for determining the number of intracellular parasites. The data represent the mean ± SD of the results of three independent experiments. The asterisks indicate significant differences between ∆lit1 (Vector) and ∆lit1 (LFR1) (Student's t test 48h, p < 0.01; 72 h, p<0.001). Figure 8 . Endocytic pathway loading with cationic ferritin rescues the intracellular growth of LFR1 null and LIT1 null L. amazonensis. BMM were pretreated for 1 h with fresh BMM medium (control) or BMM medium supplemented with 10 µg/ml cationic ferritin. BMM were infected (MOI = 1.0) for 1 h with wild type, ∆lfr1, or ∆lit1 axenic amastigotes. The BMM were washed, incubated in fresh BMM medium or BMM medium supplemented with 10 µg/ml cationic ferritin, and fixed after the indicated periods for determining the number of intracellular parasites. The data represent the mean ± SD of the results of three independent experiments. The asterisks indicate significant differences between the growth of ∆lfr1 or ∆lit1 parasites in BMM media versus BMM media supplemented with cationic ferritin (Student's t test, p < 0.0 01). (B) Phase contrast and DAPI-stained fluorescent images of BMM supplemented with or without cationic ferritin and infected with wild type, ∆lfr1, or ∆lit1 amastigotes at 48 h. The arrows indicate intracellular amastigotes. Scale bars = 5 µm.
